RxDoctor Payments Data

Michael Cotter, MD

Obstetrics & Gynecology · Gainesville, FLNPI 1669492641

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.

$1,363in general payments, 2019–2025

Across 67 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$277
  • Bayer$137
  • Caldera Medical, Inc$91
  • Coopersurgical, Inc.$85
  • Myovant Sciences Inc.$76
  • Organon$74
  • plus $623 from 23 others
$562,500in ownership & investment interests, 2019–2025

Across 9 payments — averaging $62,500 each. An ownership or investment interest held by the physician or an immediate family member.

  • Novapproach Spine, LLC$563K
  • Unified Women's Healthcare, LP$0

What the payments were for

  • Food & beverage$1,363100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,363 in reported general payments places this provider in the 60th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$7,280
Medicare patients
48
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized37$1,550
Estradiol (Twice Weekly)Estradiol14$1,231
Estradiol25$1,211

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →